Global Obesity Treatment Market Report, History and Forecast 2018-2029, Breakdown Data by Companies, Key Regions, Types and Application

Report ID: ARS10363 | Category: Agriculture | Pages: 126 | Format: PDF | Published Date: December 18,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3350.00 Multi User-$5700.00

Report Description
View Table of Contents

Report Summary

This report aims to provide a comprehensive presentation of the global market for Obesity Treatment, with and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Obesity Treatment.

The Obesity Treatment market size considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Obesity Treatment market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Obesity Treatment manufacturers, new entrants, and industry chain related companies in this market with information for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

The global Obesity Treatment market size in 2022 is 11630.0 million US dollars, and it is expected to be 33468.6 million US dollars by 2029, with a compound annual growth rate of 16.30% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Obesity Treatment market include VIVUS Inc. (US), Arena Pharmaceuticals Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Novo Nordisk A/S (Denmark), and Allergan Plc (US). The share of the top 3 players in the Obesity Treatment market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Obesity Treatment market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. Adjusting gastric Banding accounted for XX% of Obesity Treatment market in 2022. Roux-en-Y Gastric Bypass share of XX%.
Appetite suppressants accounted for XX% of the Obesity Treatment market in 2022. Combination drugs accounts for XX%.

Chapter Outline
Chapter 1: Introduces the product overview, and global Obesity Treatment market status and forecast by region.
Chapters 2-3: Segmented the global Obesity Treatment market by type, and application. Analyze the revenue of market segments from different perspectives.
Chapter 4: Analysis of the competitive environment of Obesity Treatment market participants. This mainly includes the revenue and market share of the top players, along with the players' M&A and expansion in recent years.
Chapters 5-9: Provide North America, Europe, Asia-Pacific, Latin America and Middle East & Africa Obesity Treatment market country segmentation data.
Chapter 10: Analyzes the main companies in the Obesity Treatment industry, including their main businesses, products/services, revenue, gross margin, and the latest developments.
Chapter 11: Introduces the market dynamics, the trends factors and drivers factors of the market, and the challenges and restraints faced by manufacturers in the industry.
Chapter 12: The main points and conclusions of the report.
Chapter 13: Concludes with an explanation of the data sources and research methods.

Highlights-Regions

North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
South America
Brazil
Argentina
Colombia
MEA
Saudi Arabia
Egypt
Nigeria

Player list
VIVUS Inc. (US)
Arena Pharmaceuticals Inc. (US)
F. Hoffmann-La Roche Ltd. (Switzerland)
Novo Nordisk A/S (Denmark)
Allergan Plc (US)
Medtronic (US)
Ethicon (a subsidiary of Johnson & Johnson) (US)
Cousin Biotech (France)
EnteroMedics Inc. (US)
and USGI Medical Inc. (US).

Types list
Adjusting gastric Banding
Roux-en-Y Gastric Bypass
Sleeve gastrectomy
Biliopancreatic diversion with Duodenal Switch
Endoscopic Procedures

Application list
Appetite suppressants
Combination drugs
Malabsorption
Satiety drugs

Table of Content

1 Obesity Treatment Market Overview
1.1 Obesity Treatment Product Overview
1.1.1 Obesity Treatment Product Scope
1.1.2 Obesity Treatment Market Status and Outlook
1.2 Global Obesity Treatment Market Size Overview by Region 2018 VS 2022VS 2029
1.3 Global Obesity Treatment Market Size by Region (2018-2029)
1.4 Global Obesity Treatment Historic Market Size by Region (2018-2023)
1.5 Global Obesity Treatment Market Size Forecast by Region (2023-2029)
1.6 Key Regions, Obesity Treatment Market Size (2018-2029)
1.6.1 North America Obesity Treatment Market Size (2018-2029)
1.6.2 Europe Obesity Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific Obesity Treatment Market Size (2018-2029)
1.6.4 Latin America Obesity Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa Obesity Treatment Market Size (2018-2029)
2 Obesity Treatment Market Overview by Type
2.3 Global Obesity Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.4 Global Obesity Treatment Historic Market Size by Type (2018-2023)
2.5 Global Obesity Treatment Forecasted Market Size by Type (2023-2029)
2.6 Key Regions Market Size Segment by Type (2018-2029)
2.6.1 North America Obesity Treatment Market Size Breakdown by Type (2018-2029)
2.6.2 Europe Obesity Treatment Market Size Breakdown by Type
2.6.3 Asia-Pacific Obesity Treatment Market Size Breakdown by Type
2.6.4 Latin America Obesity Treatment Market Size Breakdown by Type
2.6.5 Middle East and Africa Obesity Treatment Market Size Breakdown by Type
3 Obesity Treatment Market Overview by Application
3.3 Global Obesity Treatment Market Size by Application: 2018 VS 2022 VS 2029
3.4 Global Obesity Treatment Historic Market Size by Application (2018-2023)
3.5 Global Obesity Treatment Forecasted Market Size by Application (2023-2029)
3.6 Key Regions Market Size Segment by Application (2018-2029)
3.6.1 North America Obesity Treatment Market Size Breakdown by Application (2018-2029)
3.6.2 Europe Obesity Treatment Market Size Breakdown by Application
3.6.3 Asia-Pacific Obesity Treatment Market Size Breakdown by Application
3.6.4 Latin America Obesity Treatment Market Size Breakdown by Application
3.6.5 Middle East and Africa Obesity Treatment Market Size Breakdown by Application
4 Obesity Treatment Competition Analysis by Players
4.1 Global Obesity Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Obesity Treatment as of 2022)
4.3 Date of Key Players Enter into Obesity Treatment Market
4.4 Global Top Players Obesity Treatment Headquarters and Area Served
4.5 Key Players Obesity Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Obesity Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 North America Obesity Treatment Market Segment by Country
5.1 North America Obesity Treatment Market Size by Country (2018-2029)
5.2 United States
5.3 Canada
6 Europe Obesity Treatment Market Segment by Country
6.1 Europe Obesity Treatment Market Size by Country (2018-2029)
6.2 Germany
6.3 France
6.4 U.K.
6.5 Italy
6.6 Russia
6.7 Nordic
6.8 Rest of Europe
7 Asia-Pacific Obesity Treatment Market Segment by Country
7.1 Asia-Pacific Obesity Treatment Market Size by Region (2018-2029)
7.2 China
7.3 Japan
7.4 South Korea
7.5 Southeast Asia
7.6 India
7.7 Australia
7.8 Rest of Asia-Pacific
8 Latin America Obesity Treatment Market Segment by Country
8.1 Latin America Obesity Treatment Market Size by Country (2018-2029)
8.2 Mexico
8.3 Brazil
8.4 Rest of Latin America
9 Middle East and Africa Obesity Treatment Market Segment by Country
9.1 Middle East & Africa Obesity Treatment Market Size by Country (2018-2029)
9.2 Turkey
9.3 Saudi Arabia
9.4 UAE
9.5 Rest of Middle East & Africa
10 Manufacturers Profiles
10.1  VIVUS Inc. (US)
10.1.1 VIVUS Inc. (US) Information
10.1.2 Business Overview
10.1.3 VIVUS Inc. (US) Obesity Treatment Revenue, Gross Margin
10.1.4 Obesity Treatment Products Offered
10.1.5 VIVUS Inc. (US) Recent Development
10.2  Arena Pharmaceuticals Inc. (US)
10.2.1 Arena Pharmaceuticals Inc. (US) Information
10.2.2 Business Overview
10.2.3 Arena Pharmaceuticals Inc. (US) Obesity Treatment Revenue, Gross Margin
10.2.4 Obesity Treatment Products Offered
10.2.5 Arena Pharmaceuticals Inc. (US) Recent Development
10.3  F. Hoffmann-La Roche Ltd. (Switzerland)
10.3.1 F. Hoffmann-La Roche Ltd. (Switzerland) Information
10.3.2 Business Overview
10.3.3 F. Hoffmann-La Roche Ltd. (Switzerland) Obesity Treatment Revenue, Gross Margin
10.3.4 Obesity Treatment Products Offered
10.3.5 F. Hoffmann-La Roche Ltd. (Switzerland) Recent Development
10.4  Novo Nordisk A/S (Denmark)
10.4.1 Novo Nordisk A/S (Denmark) Information
10.4.2 Business Overview
10.4.3 Novo Nordisk A/S (Denmark) Obesity Treatment Revenue, Gross Margin
10.4.4 Obesity Treatment Products Offered
10.4.5 Novo Nordisk A/S (Denmark) Recent Development
10.5  Allergan Plc (US)
10.5.1 Allergan Plc (US) Information
10.5.2 Business Overview
10.5.3 Allergan Plc (US) Obesity Treatment Revenue, Gross Margin
10.5.4 Obesity Treatment Products Offered
10.5.5 Allergan Plc (US) Recent Development
10.6  Medtronic (US)
10.6.1 Medtronic (US) Information
10.6.2 Business Overview
10.6.3 Medtronic (US) Obesity Treatment Revenue, Gross Margin
10.6.4 Obesity Treatment Products Offered
10.6.5 Medtronic (US) Recent Development
10.7  Ethicon (a subsidiary of Johnson & Johnson) (US)
10.7.1 Ethicon (a subsidiary of Johnson & Johnson) (US) Information
10.7.2 Business Overview
10.7.3 Ethicon (a subsidiary of Johnson & Johnson) (US) Obesity Treatment Revenue, Gross Margin
10.7.4 Obesity Treatment Products Offered
10.7.5 Ethicon (a subsidiary of Johnson & Johnson) (US) Recent Development
10.8  Cousin Biotech (France)
10.8.1 Cousin Biotech (France) Information
10.8.2 Business Overview
10.8.3 Cousin Biotech (France) Obesity Treatment Revenue, Gross Margin
10.8.4 Obesity Treatment Products Offered
10.8.5 Cousin Biotech (France) Recent Development
10.9  EnteroMedics Inc. (US)
10.9.1 EnteroMedics Inc. (US) Information
10.9.2 Business Overview
10.9.3 EnteroMedics Inc. (US) Obesity Treatment Revenue, Gross Margin
10.9.4 Obesity Treatment Products Offered
10.9.5 EnteroMedics Inc. (US) Recent Development
10.10  and USGI Medical Inc. (US).
10.10.1 and USGI Medical Inc. (US). Information
10.10.2 Business Overview
10.10.3 and USGI Medical Inc. (US). Obesity Treatment Revenue, Gross Margin
10.10.4 Obesity Treatment Products Offered
10.10.5 and USGI Medical Inc. (US). Recent Development
11 Obesity Treatment Market Dynamics
11.1 Obesity Treatment Industry Trends
11.2 Obesity Treatment Growth Drivers
11.3 Obesity Treatment Market Challenges
11.4 Obesity Treatment Market Restraints
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 A Methodology
13.1.1 Research Process
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 B Data Source
13.2.1 Legal Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Obesity Treatment Market Report, History and Forecast 2018-2029, Breakdown Data by Companies, Key Regions, Types and Application

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?